Targeting Epigenetics in Cancer.

M Hanada, D Delia, A Aiello, E Stadtmauer, JC Reed, bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia Blood. ,vol. 82, pp. 1820- 1828 ,(1993) , 10.1182/BLOOD.V82.6.1820.1820

A Tefferi, T L Lasho, O Abdel-Wahab, P Guglielmelli, J Patel, D Caramazza, L Pieri, C M Finke, O Kilpivaara, M Wadleigh, M Mai, R F McClure, D G Gilliland, R L Levine, A Pardanani, A M Vannucchi, IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis Leukemia. ,vol. 24, pp. 1302- 1309 ,(2010) , 10.1038/LEU.2010.113

Steven D. Gore, Stephen Baylin, Elizabeth Sugar, Hetty Carraway, Carole B. Miller, Michael Carducci, Michael Grever, Oliver Galm, Tianna Dauses, Judith E. Karp, Michelle A. Rudek, Ming Zhao, B. Douglas Smith, Jasper Manning, Anchalee Jiemjit, George Dover, Abbie Mays, James Zwiebel, Anthony Murgo, Li-Jun Weng, James G. Herman, Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms Cancer Research. ,vol. 66, pp. 6361- 6369 ,(2006) , 10.1158/0008-5472.CAN-06-0080

M Rodriguez-Paredes, A Martinez de Paz, L Simo-Riudalbas, S Sayols, C Moutinho, S Moran, A Villanueva, M Vazquez-Cedeira, PA Lazo, F Carneiro, CS Moura, J Vieira, MR Teixeira, M Esteller, None, Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene. ,vol. 33, pp. 2807- 2813 ,(2014) , 10.1038/ONC.2013.239

Rebecca L Hancock, Kate Dunne, Louise J Walport, Emily Flashman, Akane Kawamura, Epigenetic regulation by histone demethylases in hypoxia Epigenomics. ,vol. 7, pp. 791- 811 ,(2015) , 10.2217/EPI.15.24

O. M. Sobulo, J. Borrow, R. Tomek, S. Reshmi, A. Harden, B. Schlegelberger, D. Housman, N. A. Doggett, J. D. Rowley, N. J. Zeleznik-Le, MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3) Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 8732- 8737 ,(1997) , 10.1073/PNAS.94.16.8732

V. M. Richon, T. W. Sandhoff, R. A. Rifkind, P. A. Marks, Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 10014- 10019 ,(2000) , 10.1073/PNAS.180316197

Balaji Venugopal, Richard Baird, Rebecca S. Kristeleit, Ruth Plummer, Richard Cowan, Adam Stewart, Nele Fourneau, Peter Hellemans, Yusri Elsayed, Steve Mcclue, Johan W. Smit, Ann Forslund, Charles Phelps, John Camm, T.R. Jeffry Evans, Johann S. de Bono, Udai Banerji, A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors Clinical Cancer Research. ,vol. 19, pp. 4262- 4272 ,(2013) , 10.1158/1078-0432.CCR-13-0312

Tony Reid, Frank Valone, William Lipera, David Irwin, Warren Paroly, Ron Natale, Sunil Sreedharan, Harold Keer, Bert Lum, Frank Scappaticci, Anish Bhatnagar, None, Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer Lung Cancer. ,vol. 45, pp. 381- 386 ,(2004) , 10.1016/J.LUNGCAN.2004.03.002

S S Tarighat, R Santhanam, D Frankhouser, H S Radomska, H Lai, M Anghelina, H Wang, X Huang, L Alinari, A Walker, M A Caligiuri, C M Croce, L Li, R Garzon, C Li, R A Baiocchi, G Marcucci, The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia. ,vol. 30, pp. 789- 799 ,(2016) , 10.1038/LEU.2015.308